Pharmacological approaches to cardio-renal syndrome: a role for the inodilator levosimendan
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

Pharmacological approaches to cardio-renal syndrome: a role for the inodilator levosimendan

Fedele F;Karason K;Matskeplishvili S;;
European heart journal supplements : journal of the European Society of Cardiology 2017 Vol. 19 pp. -
136
f2017europeanpharmacological

Abstract

Pathological interplay between the heart and kidneys-also known as cardio-renal syndrome (CRS)-is frequently encountered in heart failure and is linked to worse prognosis and quality of life. Drug therapies for this complex situation may include nitroprusside or the recombinant B-type natriuretic pe …

Keywords

National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine pmid:29249907 pmc5932558 doi:10.1093/eurheartj/sux002 francesco fedele kristjan karason simon matskeplishvili

Access

URL:
https://www.ncbi.nlm.nih.gov/pubmed/29249907

Citation

ID: 270908
Ref Key: f2017europeanpharmacological
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
270908
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store